Tikosyn
Product Images NDC 69189-5810

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tikosyn (NDC 69189-5810). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avera Mckennan Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dofetilide 0.25 mg Capsule (6918958101)

DOFETILIDE is a medication commonly sold under the brand name TIKOSYN. It is available in the form of capsules with a strength of 250mcg (0.25mg). The manufacturer's code is not clear and the medication is believed to be an extended-release formulation. The text also contains a series of numeric codes that may describe the product's lot number and expiration date. It is not clear what the last line "Stoux i alls" means.*

FDA Label Image

Chemical Structure (Tikosyn 01)

FDA Label Image

Figure 1 (Tikosyn 02)

This is a table that shows the mean change from baseline QTc (in milliseconds) on day 1 and day 23 (steady state), along with the mean plasma dofetilide concentration (in ng/mL) numbered from 1 to 4.*

FDA Label Image

Figure 2 (Tikosyn 03)

FDA Label Image

Figure 3 (Tikosyn 04)

FDA Label Image

Figure 4 (Tikosyn 05)

This appears to be a table of dosing information and statistical values for the medication Dofetilide in varying amounts. The table includes the dosing amounts in micrograms (mcg) and megaliters (meg), as well as p-values from a Log Rank Test. The values appear to be time-based, potentially indicating a study of the medication's effectiveness over a span of 12 months.*

FDA Label Image

Flow Chart (Tikosyn 06)

This appears to be a medical document providing guidelines regarding the use of dofetilide, a medication used to treat irregular heartbeats. The document instructs medical staff to place a patient on telemetry and check their baseline QTC (a measure of the electrical conductivity of the heart). If the QTC is below a certain level, dofetilide may be administered in varying doses depending on the patient's calculated creatinine clearance (a measure of kidney function). If the QTC increases too much after the medication is administered, the dosage should be adjusted or discontinued.*

FDA Label Image

Logo (Tikosyn 07)

The text describes that the product is distributed by Pfizer Labs, which is a division of Pfizer Inc, located in NY, NY 10017.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.